» Articles » PMID: 30229533

Problems Persist in Reporting of Methods and Results for the WOMAC Measure in Hip and Knee Osteoarthritis Trials

Overview
Journal Qual Life Res
Date 2018 Sep 20
PMID 30229533
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is a commonly used outcome measure for osteoarthritis. There are different versions of the WOMAC (Likert, visual analogue or numeric scales). A previous review of trials published before 2010 found poor reporting and inconsistency in how the WOMAC was used. This review explores whether these problems persist.

Methods: This systematic review included randomised trials of hip and/or knee osteoarthritis published in 2016 that used the WOMAC. Data were extracted on the version used, score range, analysis and results of the WOMAC, and whether these details were clearly reported.

Results: This review included 62 trials and 41 reported the WOMAC total score. The version used and item range for the WOMAC total score were unclear in 44% (n = 18/41) and 24% (n = 10/41) of trials, respectively. The smallest total score range was 0-10 (calculated by averaging 24 items scored 0-10); the largest was 0-2400 (calculated by summing 24 items scored 0-100). All trials reported the statistical analysis methods but only 29% reported the between-group mean difference and 95% confidence interval.

Conclusion: Details on the use and scoring of the WOMAC were often not reported. We recommend that trials report the version of the WOMAC and the score range used. The between-group treatment effect and corresponding confidence interval should be reported. If all the items of the WOMAC are collected, the total score and individual subscale scores should be presented. Better reporting would facilitate the interpretation, comparison and synthesis of the WOMAC score in trials.

Citing Articles

A Single Surgeon Experience of Selective Patellar Resurfacing During Primary Total Knee Arthroplasty.

Woelfle C, Cooper H Arthroplast Today. 2024; 30:101563.

PMID: 39634105 PMC: 11615874. DOI: 10.1016/j.artd.2024.101563.


Assessing the measurement properties of PROMIS Computer Adaptive Tests, short forms and legacy patient reported outcome measures in patients undergoing total hip arthroplasty.

Braaksma C, Wolterbeek N, Veen M, Poolman R, Pronk Y, Klaassen A J Patient Rep Outcomes. 2024; 8(1):121.

PMID: 39432233 PMC: 11493881. DOI: 10.1186/s41687-024-00799-5.


Does Robotic Assisted Technique Improve Patient Utility in Total Knee Arthroplasty? A Comparative Retrospective Cohort Study.

Ratti M, Ceriotti D, Rescinito R, Bibi R, Panella M Healthcare (Basel). 2024; 12(16).

PMID: 39201208 PMC: 11353423. DOI: 10.3390/healthcare12161650.


Characterization of clinical data for patient stratification in moderate osteoarthritis with support vector machines, regulatory network models, and verification against osteoarthritis Initiative data.

Segarra-Queralt M, Galofre M, Tio L, Monfort J, Monllau J, Piella G Sci Rep. 2024; 14(1):11797.

PMID: 38782951 PMC: 11116450. DOI: 10.1038/s41598-024-62212-x.


Clinical Assessment of Osteoarthritis Pain: Contemporary Scenario, Challenges, and Future Perspectives.

Sethi V, Anand C, Della Pasqua O Pain Ther. 2024; 13(3):391-408.

PMID: 38662319 PMC: 11111648. DOI: 10.1007/s40122-024-00592-8.


References
1.
Wolfe F, Kong S . Rasch analysis of the Western Ontario MacMaster questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Ann Rheum Dis. 1999; 58(9):563-8. PMC: 1752940. DOI: 10.1136/ard.58.9.563. View

2.
Dougados M, Leclaire P, van der Heijde D, Bloch D, Bellamy N, Altman R . Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. Osteoarthritis Cartilage. 2000; 8(6):395-403. DOI: 10.1053/joca.2000.0361. View

3.
Bolognese J, Schnitzer T, Ehrich E . Response relationship of VAS and Likert scales in osteoarthritis efficacy measurement. Osteoarthritis Cartilage. 2003; 11(7):499-507. DOI: 10.1016/s1063-4584(03)00082-7. View

4.
Bellamy N, Kean W, BUCHANAN W, Campbell J . Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis Index. J Rheumatol. 1992; 19(1):153-9. View

5.
Gossec L, Hawker G, Davis A, Maillefert J, Lohmander L, Altman R . OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. J Rheumatol. 2007; 34(6):1432-5. View